DI IANNI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 3.763
AS - Asia 2.554
EU - Europa 2.027
SA - Sud America 316
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 8.708
Nazione #
US - Stati Uniti d'America 3.683
SG - Singapore 1.161
CN - Cina 811
IT - Italia 504
IE - Irlanda 360
SE - Svezia 358
TR - Turchia 279
BR - Brasile 276
UA - Ucraina 241
DE - Germania 147
VN - Vietnam 127
GB - Regno Unito 101
RU - Federazione Russa 77
FR - Francia 53
CA - Canada 44
IN - India 38
FI - Finlandia 32
MX - Messico 30
HK - Hong Kong 26
NL - Olanda 24
PL - Polonia 22
BD - Bangladesh 18
ES - Italia 18
AR - Argentina 16
BE - Belgio 16
ZA - Sudafrica 16
AT - Austria 15
GR - Grecia 12
KR - Corea 12
JP - Giappone 11
RO - Romania 9
PK - Pakistan 8
ID - Indonesia 7
CH - Svizzera 6
CO - Colombia 6
EC - Ecuador 6
EU - Europa 6
IQ - Iraq 6
MA - Marocco 6
MY - Malesia 6
SA - Arabia Saudita 6
AL - Albania 5
CZ - Repubblica Ceca 5
EG - Egitto 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CL - Cile 4
HU - Ungheria 4
IL - Israele 4
IR - Iran 4
LT - Lituania 4
TH - Thailandia 4
VE - Venezuela 4
AU - Australia 3
KE - Kenya 3
PE - Perù 3
BG - Bulgaria 2
BW - Botswana 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GD - Grenada 2
JO - Giordania 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
SY - Repubblica araba siriana 1
TV - Tuvalu 1
UY - Uruguay 1
Totale 8.708
Città #
Singapore 910
Chandler 550
Jacksonville 403
Dublin 356
Ashburn 247
Beijing 214
Dallas 186
Princeton 176
Izmir 153
Santa Clara 146
Los Angeles 141
Nanjing 138
Altamura 93
Dearborn 89
The Dalles 78
Cambridge 72
Pescara 70
Boardman 69
Ann Arbor 68
Wilmington 64
Nanchang 56
Ho Chi Minh City 44
New York 42
Redondo Beach 39
Tongling 37
Chieti 36
Woodbridge 36
Buffalo 35
Milan 33
Washington 33
Hefei 32
São Paulo 32
Hanoi 30
Hebei 29
Hong Kong 26
Kunming 22
Seattle 21
Tianjin 21
Shenyang 20
Warsaw 20
Munich 19
Norwalk 19
Brooklyn 18
Chicago 16
Romola 16
Montreal 15
Jiaxing 14
Lappeenranta 14
Rome 14
San Francisco 14
Helsinki 13
Houston 13
Mexico City 13
Nuremberg 13
Phoenix 13
Boston 12
Brussels 12
Dong Ket 12
London 12
Orem 12
Seoul 12
Hangzhou 11
Mumbai 11
Chennai 10
Denver 10
Johannesburg 10
Rio de Janeiro 10
Tokyo 10
Stockholm 9
Ascoli Piceno 8
Belo Horizonte 8
Kocaeli 8
Shanghai 8
Vienna 8
Changsha 7
Istanbul 7
Manchester 7
Mordano 7
Toronto 7
Bologna 6
Changchun 6
Düsseldorf 6
Frankfurt am Main 6
Jinan 6
L'aquila 6
Lanzhou 6
San Martino In Pensilis 6
Amsterdam 5
Atlanta 5
Brno 5
Dhaka 5
Francavilla al Mare 5
Haiphong 5
Islamabad 5
Paris 5
Porto Alegre 5
Secaucus 5
Tashkent 5
Terni 5
Topeka 5
Totale 5.432
Nome #
A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders. 140
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 127
beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction. 125
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo 118
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor α 118
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 118
T lymphocyte transduction with herpes simplex virus-thymidine kinase (HSV-tk) gene: comparison of four different infection protocols. 117
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications 117
Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT 116
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation 115
5-Azacytidine prevents transgene methylation in vivo 113
CD19.CAR-T cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy 112
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion 112
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation 110
Primary eyelid plasmacytoma 109
Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models 105
Secondary solid cancer following hematopoietic cell transplantation in patients with thalassemia major 104
To breathe or not to breathe: The haematopoietic stem/progenitor cells dilemma 104
Minimum information about T regulatory cells: A step toward reproducibility and standardization 104
G-CSF-induced thrombocytopenia in a healthy donor 102
Retroviral transfer of herpes simplex virus-thymidine kinase and beta-galactosidase genes into U937 cells with bicistronic vector 102
MtDNA mutation associated with mitochondrial dysfunction in megakaryoblastic leukaemic cells 101
"Designed" grafts for HLA-haploidentical stem cell transplantation 101
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 100
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy 99
Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells 98
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation 97
Tregs: Hype or hope for allogeneic hematopoietic stem cell transplantation? 97
NeoR-based transduced T lymphocytes detected by real-time quantitative polymerase chain reaction 97
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 95
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection 95
Interleukin 7-engineered stromal cells: A new approach for hastening naive T cell recruitment 95
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: Implications for cellular-based therapy 95
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL 94
Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and enhanced green fluorescence protein genes in primary T lymphocytes 94
Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosis [1] 94
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 94
Next generation HLA-haploidentical HSCT 94
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells 92
Chronic myeloproliferative disorders: The bone marrow stromal component is not involved in the malignant clone [13] 91
Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment 91
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice 90
The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma 90
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 90
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 90
T regulatory cell separation for clinical application 89
Mesenchymal cells recruit and regulate T regulatory cells 89
Unusual onset of venous thromboembolism and heparin-induced thrombocytopenia in a patient with essential thrombocythemia 89
NOTCH and graft-versus-host disease 89
Hematopoietic stem/progenitor cells express myoglobin and neuroglobin: Adaptation to hypoxia or prevention from oxidative stress? 89
The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells 88
Interleukin-7-Engineered Mesenchymal Cells: In Vitro Effects on Naive T-Cell Population 88
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation 87
Mesenchymal cells: A vehicle for gene therapy 87
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study 87
Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production 87
NOTCH1 aberrations in Chronic lymphocytic leukemia 86
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 86
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation. 85
Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy 85
Recurrent primary plasmacytoma of the eyelid with rapid regional metastasis 85
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 85
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL 84
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 84
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation 84
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 82
A novel NOTCH1 PEST domain mutation in a case of chronic lymphocytic leukemia 82
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 82
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma 81
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma 80
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option 80
In vivo demethylation of a MoMuLV retroviral vector expressing the herpes simplex thymidine kinase suicide gene by 5' azacytidine. 80
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity 80
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 80
Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses 79
Melphalan versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for low-risk multiple myeloma 78
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation 78
A new genetic lesion in B-CLL: A NOTCH1 PEST domain mutation 77
Immunomagnetic isolation of CD4+CD25+FoxP3 + natural T regulatory lymphocytes for clinical applications 76
Graft engineering for allogeneic haploidentical stem cell transplantation 76
Myelofibrosis and allogeneic transplantation: critical points and challenges 75
Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation 73
NOTCH1 is aberrantly activated in chronic lymphocytic leukemia hematopoietic stem cells 73
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party 71
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders [6] 69
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 68
Large-scale generation of human allodepleted anti-3rd party lymphocytes 68
Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics 67
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 65
Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation 64
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 63
Case Report: A case of pediatric persistent refractory ITP responsive to avatrombopag 62
Comparison between peripheral blood progenitor cell collection on the 4th or 5th day of granulocyte colony-stimulating factor treatment in allogeneic stem cell donors: implications for hematopoietic progenitor cell apheresis guidelines 62
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 62
NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: De-novo origin? 61
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial 60
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 60
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial 59
Allogeneic stem cell transplantation in multiple myeloma: is there still a place? 55
The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein 54
Totale 8.877
Categoria #
all - tutte 39.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.371


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021321 0 0 0 0 0 157 8 8 26 26 2 94
2021/2022409 2 9 18 40 37 9 7 33 33 40 39 142
2022/20231.476 120 195 85 188 171 269 74 117 156 17 43 41
2023/2024698 54 23 60 29 67 155 153 36 22 45 10 44
2024/20252.302 121 542 502 86 44 79 102 122 182 80 243 199
2025/20261.988 386 227 437 432 468 38 0 0 0 0 0 0
Totale 9.420